Abrescia N - Search Results

1

Immunologic abnormalities in patients with chronic delta infection.

Castello G, Ciampi R, Leonardi E, Abrescia N, Ronga D, D'Alessio V. Castello G, et al. Among authors: abrescia n. Boll Ist Sieroter Milan. 1988;67(5-6):337-44. Boll Ist Sieroter Milan. 1988. PMID: 2908737

2

Presence of delta antigen in liver biopsies of HBsAg positive patients with chronic liver diseases living in the Naples area.

Picciotto L, Abrescia N, Ciampi R. Picciotto L, et al. Among authors: abrescia n. Boll Soc Ital Biol Sper. 1983 Jan 31;59(2):189-91. Boll Soc Ital Biol Sper. 1983. PMID: 6860493

3

Prevalence of HBV and HDV markers in families of patients with HBsAg+ chronic liver disease.

Ciampi R, Abrescia N, Villari R, Memoli AM, Isabella L, Picciotto L. Ciampi R, et al. Among authors: abrescia n. Prog Clin Biol Res. 1987;234:381-2. Prog Clin Biol Res. 1987. PMID: 3628390 No abstract available.

4

Prevalence of intranuclear particles in liver pathologies.

Borgia G, Cicciarello S, Crowell J, Lambiase A, Ciampi R, Reynaud L, Abrescia N, Piazza M. Borgia G, et al. Among authors: abrescia n. Boll Soc Ital Biol Sper. 1989 Apr;65(4):321-7. Boll Soc Ital Biol Sper. 1989. PMID: 2775539

5

[Demonstration of the interchangeability of 2 types of recombinant anti-hepatitis-B vaccine].

Piazza M, Abrescia N, Picciotto L, Orlando R, Cerini R, Borgia G, Cotugno M. Piazza M, et al. Among authors: abrescia n. Boll Soc Ital Biol Sper. 1993 Apr;69(4):273-80. Boll Soc Ital Biol Sper. 1993. PMID: 8129908 Clinical Trial. Italian.

6

Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study.

Marchetti G, Cozzi-Lepri A, Tincati C, Calcagno A, Ceccherini-Silberstein F, De Luca A, Antinori A, Castagna A, Puoti M, Monforte Ad; Icona Foundation Study Group. Marchetti G, et al. BMC Infect Dis. 2014 Feb 12;14:79. doi: 10.1186/1471-2334-14-79. BMC Infect Dis. 2014. PMID: 24520976 Free PMC article.

7

Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects.

Skowron G, Spritzler JG, Weidler J, Robbins GK, Johnson VA, Chan ES, Asmuth DM, Gandhi RT, Lie Y, Bates M, Pollard RB; NIH/NIAID ACTG 384 Protocol Team and Monogram Biosciences. Skowron G, et al. J Acquir Immune Defic Syndr. 2009 Mar 1;50(3):250-8. doi: 10.1097/QAI.0b013e3181938faf. J Acquir Immune Defic Syndr. 2009. PMID: 19194319 Free PMC article. Clinical Trial.

8

Immunogenicity of a DNA-recombinant hepatitis B vaccine (Engerix B) given at 3, 5 and 11 months of age with a new schedule suitable for mass vaccination programmes.

Piazza M, Da Villa G, Picciotto L, Abrescia N, Guadagnino V, Vegnente A, Iorio R, Cimmino L, Memoli AM. Piazza M, et al. Among authors: abrescia n. Boll Soc Ital Biol Sper. 1989 Oct;65(10):1003-8. Boll Soc Ital Biol Sper. 1989. PMID: 2533872

9

[Adaptability of the anti-hepatitis-B vaccine Recombivax HB to the Piazza protocol for the mass vaccination of newborn infants].

Piazza M, Abrescia N, Picciotto L, Cotugno M, Vegnente A, Iorio R, Cimmino L. Piazza M, et al. Among authors: abrescia n. Boll Soc Ital Biol Sper. 1992 Jul;68(7):483-9. Boll Soc Ital Biol Sper. 1992. PMID: 1482565 Italian.

10

Ultrastructural changes in mouse liver cells: a morphometric study on the influence of morphine, heroin, and cardiostenol.

Borgia G, Crowell J, Cocchiararo M, Abrescia N, Lambiase A, D'Alfonso G, Schreil W, Piazza M. Borgia G, et al. Among authors: abrescia n. J Ultrastruct Res. 1982 Aug;80(2):123-32. doi: 10.1016/s0022-5320(82)90012-0. J Ultrastruct Res. 1982. PMID: 7120535 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters